TLIS

Talis Biomedical Corporation Common Stock
TLIS

Overview Fund Activity
Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

47 hedge funds and large institutions have $70.2M invested in Talis Biomedical Corporation Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
11
Reduced
16
Closed
5
Calls
$84K
Puts
$74K
Net Calls
+$10K
Net Calls Change
-$1.78M

Top Buyers

1
GC
1
Greenlight Capital
New York
$6.29M
2
PCM
2
Prelude Capital Management
New York
$755K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.91M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$315K
5
BBA
5
Baker Bros. Advisors
New York
$30.6M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
NIP
2
Nicholas Investment Partners
California
$0
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$19.7M
4
Morgan Stanley
4
Morgan Stanley
New York
$708K
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$219K
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$30.6M 7,624,835 +50,000 +0.7%
ACH
2
ArrowMark Colorado Holdings
Colorado
$19.7M 4,915,239 -978,637 -17%
GC
3
Greenlight Capital
New York
$6.29M 1,569,300 +1,569,300 New
BlackRock
4
BlackRock
New York
$3.27M 816,031 +2,894 +0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.91M 725,133 +156,376 +27%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.13M 281,565 -21,403 -7%
State Street
7
State Street
Massachusetts
$1.07M 266,307 +27,720 +12%
PCM
8
Prelude Capital Management
New York
$755K 188,269 +175,932 +1,426%
Morgan Stanley
9
Morgan Stanley
New York
$708K 176,334 -138,280 -44%
Northern Trust
10
Northern Trust
Illinois
$511K 127,628 -2,989 -2%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$476K 118,703 +35,635 +43%
Two Sigma Investments
12
Two Sigma Investments
New York
$315K 78,628 +78,628 New
PPA
13
Parametric Portfolio Associates
Washington
$305K 75,938 -2,034 -3%
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
$237K 59,161 +35,863 +154%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$219K 54,546 -33,300 -38%
Bank of America
16
Bank of America
North Carolina
$193K 48,023 -17,371 -27%
Nuveen Asset Management
17
Nuveen Asset Management
Illinois
$186K 50,287 -4,197 -8%
Charles Schwab
18
Charles Schwab
California
$148K 36,714 – –
PP
19
PDT Partners
New York
$140K 34,890 +4,781 +16%
Citadel Advisors
20
Citadel Advisors
Florida
$139K 34,707 +8,561 +33%
BCM
21
Bridgeway Capital Management
Texas
$130K 32,500 +32,500 New
Two Sigma Advisers
22
Two Sigma Advisers
New York
$100K 24,900 +24,900 New
GSEP
23
Golden State Equity Partners
California
$89K 22,133 +22,133 New
M&T Bank
24
M&T Bank
New York
$55K 13,670 -1,532 -10%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$50K 12,581 – –
1
2 3